GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE327nnn/GSE327189/primary200OKTranscriptomicsHomo sapiens OtherExpression profiling by high throughput sequencinghttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE327189GEOGSEfalseViral-based individualized neoantigen vaccine as adjuvant treatment in resected head and neck squamous cell carcinoma: immunogenicity and efficacy from a randomized Phase I trialTG4050 is a personalized vaccine targeting point mutations of the tumors.. This study allows the characterization of transcriptome and vdj rearrangements of tumor antigen specific CD8+ T cells elicited by personalized vaccines.2026/06/23GSE327189GSM9651078GSM9651077GSM9651079GSM9651081GSM965108015520327189Homo sapiens